SCHEMBL6172003

SCHEMBL6172003

CC(c1ccncc1Oc1ccccc1)C1(C(C)c2ccncc2Oc2ccccc2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.37
CYP3A4 P08684 1/20 0.35
GAA P10253 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
POLB P06746 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PTGS1 P23219 3/20 0.35
PTGS2 P35354 3/20 0.35
NPBWR1 P48145 2/20 0.35
MCHR1 Q99705 2/20 0.35
LMNA P02545 2/20 0.34
OPRL1 P41146 1/20 0.34
CTSD P07339 1/20 0.34
BACE1 P56817 1/20 0.34
BACE2 Q9Y5Z0 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
ELOVL6 Q9H5J4 1/20 0.34
ELOVL3 Q9HB03 1/20 0.34
LIPE Q05469 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173690 0.89 CYP3A4 (0.41) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL2941010 0.87 CYP3A4 (0.36) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6174812 0.86 ALDH1A1 (0.38) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6173899 0.85 ALDH1A1 (0.39) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6173429 0.85 POLB (0.41) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6172522 0.83 CYP3A4 (0.40) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6175907 0.82 ALDH1A1 (0.39) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6172582 0.82 ALDH1A1 (0.36) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6173440 0.81 CYP3A4 (0.38) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6173283 0.81 CYP3A4 (0.38) ALDH1A1CYP3A4GAACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed